# Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma

> **NCT01791894** · PHASE1,PHASE2 · COMPLETED · sponsor: **Stanford University** · enrollment: 5 (actual)

## Conditions studied

- Basal Cell Carcinoma of the Skin
- Recurrent Skin Cancer

## Interventions

- **DRUG:** arsenic trioxide

## Key facts

- **NCT ID:** NCT01791894
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2013-11
- **Final completion:** 2015-11
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2018-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01791894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01791894, "Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01791894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*